Beijing, China

Wei Yu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2023-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Wei Yu - Innovator in Medical and Route Processing Technologies

Introduction

Wei Yu is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of medical technology and route processing systems. With a total of two patents to his name, his work demonstrates a commitment to advancing technology for practical applications.

Latest Patents

Wei Yu's latest patents include a "System and method for predicting susceptibility of genusto amikacin." This innovative system features a calculating unit with a computer-readable storage medium that executes a program to predict susceptibility with an impressive accuracy rate of about 98.8%. The method involves calculating a k value and determining the Exp(−k) power value using Euler's constant. His second patent, "Route processing method and apparatus," focuses on acquiring vehicle driving routes and determining target road sections in high definition maps, enhancing navigation accuracy.

Career Highlights

Wei Yu has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Hangzhou Matrix Biotechnology Co Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in both medical and technological fields.

Collaborations

Throughout his career, Wei Yu has collaborated with notable colleagues, including Qiwen Yang and Jing Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Wei Yu's contributions to technology, particularly in medical applications and route processing, highlight his role as a significant inventor. His patents reflect a dedication to improving accuracy and efficiency in critical areas of research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…